The effects ofplatelet-derived growth factor (PDGF) were studied in isolated rings of rat aorta contracted submaximally to phenylephrine. The BB isoform of PDGF elicited relaxation in rings with endothelium and further contraction in rings without endothelium. Both the endothelium-dependent relaxation and endothelium-independent contraction occurred at concentrations known to induce PDGF receptor-mediated responses in cultured cells. Furthermore, the relaxation was isoform specific. This conclusion is supported by the unique ability of PDGF-BB to induce endothelium-dependent relaxations, as well as by studies showing isoform specific, concentration-dependent desensitization of PDGF-BB relaxation. The relaxation induced by PDGF-BB was prevented by Nw-nitro-L-arginine. It was also observed that endothelium-independent contractions to the AB and AA isoforms of PDGF were less than those to PDGF-BB. Contrary to the widely held view that PDGF receptors are not present on the endothelium of macrovessels, these studies provide evidence for an endothelium-dependent, nitric oxide mediated relaxation of rat aorta caused by PDGF via PDGF, 8, 
Introduction
Platelet-derived growth factor (PDGF)' is a peptide dimer known to exist in three isoforms (BB, AB, and AA) that exerts its biological effects via three different receptor types (##, a#, and aa). It is a potent mitogen and has been implicated in the vascular response to injury and the pathogenesis ofatherosclerosis and hypertension (1) (2) (3) . These conditions are associated with cell proliferation and/or migration as well as abnormal vasomotor responses (1) (2) (3) (4) (5) (6) (7) . PDGF is expressed in the walls of normal arteries under circumstances where cell turnover is low, suggesting that PDGF may have important nonmitogenic functions (8) . Based on studies showing that PDGF causes endothelium-independent contractions of vascular strips in vitro, 1 . Abbreviations used in this paper: Ach, Acetylcholine; NNA, NW-nitro-L-arginine; PDGF, platelet-derived growth factor; PE, phenylephrine; PSS, physiological salt solution.
it is thought that PDGF may have a role in the modulation of vascular tone (9) .
Recent studies of cultured microvascular endothelial cells have shown that PDGF receptors are present on these cells and that treatment with PDGF results in phosphorylation of the PDGF receptor, increases in glucose and basic amino acid uptake and stimulation of DNA synthesis (10, 1 1). However, it is a widely held view that PDGF receptors are not present on the endothelium of large vessels (10) (11) (12) (13) (14) (15) (16) (17) (18) . Also, it is not known if the interaction ofPDGF with endothelial cell receptors is capable of eliciting changes in vascular tone. The purpose of this study was to determine possible endothelium-dependent vasoactive effects of PDGF in macrovessels and to characterize these responses.
Methods
Aortic rings. Descending thoracic aortae were excised from male Wistar rats (276-300 g) killed by exsanguination after anesthesia with ketamine (80 mg/kg i.m.) and xylazine (14 mg/kg i.m.) and anticoagulation with sodium heparin (100 U i.v.). The aortae were cleaned ofadherent connective tissue and cut into transverse rings 4 mm in length. The endothelium was removed from some rings by inserting small forceps into the lumen and gently rolling the ring on moistened filter paper ( 19).
Vasoactive effects ofPDGF isoforms. To study possible changes of isometric circumferential force in response to PDGF, rings with and without endothelium were suspended from strain gauges in organ baths containing 7 ml of physiological salt solution (PSS) of the following composition (mM): NaCl 118.3, KCl 4.7, MgSO4 1.2, KH2PO4 1.2, CaC12 2.5, NaHCO3 25, Na2-EDTA 0.026, and glucose 11.0. Once mounted, the rings were maintained at 370C and gassed with 95% 0J5% CO2. The rings were stretched stepwise to a resting tension of 5 g, allowed to equilibrate for 60 min and then contracted with the aadrenergic agonist phenylephrine (PE) to 40% ofa maximal contraction to potassium (120 mM) for all studies. Mechanical denudation of the endothelium had no significant effect on either maximal contractions to potassium ( 120 mM), or the concentration of PE required to achieve 40% ofthe potassium contraction (data not shown). The Effect ofcyclooxygenase and nitric oxide inhibition on PDGF-BB relaxations. The effect of cyclooxygenase inhibition on the endothelium-dependent relaxation to PDGF-BB was studied by adding indomethacin (1.0 MM) to the organ chamber 30 min before beginning the PDGF-BB concentration response. To test the ability ofan inhibitor of nitric oxide synthesis to prevent relaxation to PDGF-BB, some rings were treated for 30 min with the arginine analog Nw-nitro-L-arginine (NNA, 30 MM). After the 30 min treatment, the PSS containing NNA was replaced with PSS that did not contain NNA. The treated rings were allowed to equilibrate for -20 min before beginning the PDGF concentration response. To test the ability of L-arginine (100 MM) to reverse the effects of NNA, this amino acid was added to the chamber for the 20-min equilibration period following NNA treatment and was present throughout the PDGF concentration response.
Drugs. Human recombinant PDGF was used throughout (PDGF-BB and PDGF-AA from PeproTech Inc., Rocky Hill, NJ; PDGF-AB from Upstate Biotechnology, Inc., Lake Placid, NY). Concentrations of PDGF were calculated using a calculated average molecular weight of 25 kD for all three PDGF isoforms. Acetylcholine chloride, L-phenylephrine hydrochloride, indomethacin, and Nw-nitro-L-arginine were obtained from Sigma Chemical Co. (St. Louis, MO) .
Data analysis. All responses are expressed as a percentage ofPE-induced tone. Data are presented as means±SEM. For all experiments, n equals the number ofrats from which rings ofaorta were taken. Significant differences between concentration-response curves and responses induced by a single concentration of agonist were determined by the Student t test for unpaired observations. Contractile concentration-response curves to PDGF were compared by analysis ofvariance. Results were considered statistically significant when P < 0.05.
Results
Responses ofrings with and without endothelium to PDGF. In rings denuded of endothelium, all three isoforms of PDGF caused slight contractions, although contractions caused by PDGF-BB (n = 4) were significantly larger than those elicited by either PDGF-AB (n = 6) or PDGF-AA (n = 5, P < 0.01; Fig.  1 , a and c). The maximal degree of contraction caused by PDGF-BB (1,200 pM) was modest, averaging 0.76±0.18 g or 13.6±2.8% of the maximal tone induced by depolarization with potassium (120 mM, 5.4±0.4 g, n = 4). In contrast, in rings that had an intact endothelium, PDGF-BB caused concentration-dependent relaxations (Fig. 1, b and d) . At similar concentrations, PDGF-AB produced mild contractions and PDGF-AA had virtually no effect (Fig. 1 d) .
Effect ofincubation with PDGF isoforms on PDGF-BB relaxations. Cumulative data showing the effects on PDGF-BB relaxation of 3 h incubation without or with each of the three PDGF isoforms are shown in Fig. 2 a. Incubation in the absence ofPDGF had no effect on PDGF-BB induced relaxations (n = 12, Fig. 2 a) . Incubation with 400 pM PDGF-BB completely blocked the endothelium-dependent relaxations to PDGF-BB (n = 8, Fig. 2 a) . Incubation with either PDGF-AB (400 pM, n = 9) or PDGF-AA (400 pM, n = 8) had no significant effect on the subsequent PDGF-BB induced relaxations (Fig. 2 a) . Relaxations to the endothelium-dependent vasodilator, Ach, following the concentration-response to PDGF-BB were not affected by any ofthe incubation conditions (Table I) Fig. 3 ). (9) . This, in addition to their finding that incubation with PDGF had no effect on Achinduced relaxation of intact rat aortic strips, led them to the conclusion that PDGF exerts its vasoactive effects in an endothelium-independent manner. This conclusion is in agreement with studies ofcultured cells that show macrovascular endothelial cells do not respond to PDGF, presumably because they lack PDGF receptors (10) (11) (12) (13) (14) (15) (16) (17) (18) . The observation of endothelium-independent responses to PDGF-AB and AA in the present study lends support to this view. However, the demonstration of endothelium-dependent relaxations in response to PDGF-BB suggests that PDGF can act on the endothelium of large vessels, but that such interactions may be isoform specific. The isoform-specific endothelium-mediated effects of PDGF would not have been apparent in the studies by Berk and colleagues as the PDGF preparation used was a mixture of PDGF isoforms (9, 20) . Block et al. have also described endothelium-independent contractions to PDGF, but these and other studies were conducted without first inducing active vascular tone (9, 21, 22) . These differences from the present study could account for the absence ofan effect ofthe endothelium in earlier reports. A third possibility is that the agonist used to constrict the vessels in the present study stimulated the expression of endothelial cell PDGF receptors, a phenomenon that has been described in cultured vascular smooth muscle cells (23) . Even this explanation presumes a capacity for de novo synthesis of PDGF receptors by the aortic endothelium. It is however, still an unsatisfactory explanation of the endothelium-dependent response described, given the short period of time between exposure to the contractile agonist and the PDGF concentration response. A less likely possibility is that in the present study PDGF-BB caused endothelium-dependent relaxations indirectly by first acting on PDGF #3-receptors in the underlying smooth muscle. Thus, the discovery of an isoform-specific, endothelium-dependent relaxation of rat aortic rings to PDGF-BB is the first evidence for an endothelium-mediated effect of PDGF on vascular smooth muscle. PDGF-BB initiated endothelium-dependent relaxations at concentrations approximately 10-fold higher than those required for vasoconstriction (Fig. 1) . It has been noted by others that PDGF induces contractions of vascular strips at concentrations lower than those required for stimulating either maximal increases in intracellular calcium or growth (9, 21 laxations. This result can be interpreted to indicate that the relaxations were due to the interaction ofPDGF-BB with endothelial cell (3-receptors.
The isoform-specificity of the endothelium-dependent relaxation to PDGF is further supported by incubation studies conducted with each PDGF isoform. Reports from studies of cultured cells have shown that incubation with PDGF under conditions similar to the ones employed in this study is sufficient to cause isoform-specific downregulation ofPDGF receptors and a consequent reduction in PDGF binding (24) (25) (26) . PDGF-BB was the only isoform to inhibit the endothelium-dependent relaxation to PDGF following incubation, consistent with an isoform specific downregulation of 3(-receptors. Failure ofincubation with either PDGF-AB or PDGF-AA to block the endothelium-dependent relaxation is presumably due to the inability of these isoforms to bind at (3(-receptors. The inhibitory effect of incubation with PDGF-BB was concentration-dependent, and even a concentration of PDGF-BB that did not elicit relaxation (40 pM) was able to significantly inhibit subsequent endothelium-dependent relaxation to PDGF-BB. Furthermore, inhibition occurred without affecting endothelium-dependent responses to Ach. These results suggest that the effects of incubation with PDGF-BB were specific for PDGF-induced relaxation and not due to nonspecific desensitization of the endothelium or the underlying smooth muscle. These findings are consistent with inhibition that results from PDGF receptor downregulation. Also, the ready availability of PDGF from platelets and the ability ofvascular smooth muscle and endothelial cells to produce and secrete PDGF (2, 21) suggests that the ability of the endothelium to respond to PDGF and exert effects on the smooth muscle may be subject to autocrine or paracrine modulation.
Endothelium-dependent vasodilators act by causing the release of vasoactive prostanoids (27) or the endothelium-derived relaxing factor, nitric oxide (28) . The apparent insensitivity of the endothelium-dependent relaxation to the cyclooxygenase inhibitor indomethacin indicates that the relaxation to PDGF-BB was probably not due to endothelium-derived prostanoids. It is now recognized that endothelium-derived nitric oxide, an activator of soluble guanylate cyclase, is synthesized from L-arginine and that certain L-arginine analogs act as competitive inhibitors of nitric oxide synthesis (28) (29) (30) (31) . In this study, the ability of the arginine analog NNA to completely block the relaxation of PDGF-BB and unmask contractions is comparable to those seen in rings denuded of endothelium, and strongly suggests that the endothelium-dependent relaxation to PDGF-BB is the result of nitric oxide release. The observation that relaxations to sodium nitroprusside were not affected by NNA, coupled with the partial restoration of relaxation to PDGF-BB by supplementation of NNA treated rings with L-arginine, indicate the specificity ofNNA for nitric oxide synthase (30) . That L-arginine was capable of only partially restoring the endothelium-dependent relaxation is not unexpected, given the potency of this particular arginine analog (31) . In separate studies, PDGF-BB also caused endotheliumdependent, NNA-inhibitable, relaxations of porcine coronary artery, but not of rabbit thoracic aorta (data not shown).
This study demonstrates that PDGF-BB causes an isoform specific, endothelium-dependent relaxation of isolated rat aorta. Further (32) , possibly by releasing nitric oxide (33) that may serve to counteract the direct proliferative effect that PDGF has on the smooth muscle. The loss of this internal control early in vascular diseases featuring abnormal endothelium-dependent responses may help explain the subsequent proliferation of smooth mus- cle cells that often occurs as a part ofthe vascular response and which characterizes the pathogenesis of these diseases.
